Interstitial lung disease is a dominant feature in patients with circulating myositis-specific antibodies
Abstract Background Many patients with polymyositis (PM) or dermatomyositis (DM) have circulating myositis-specific antibodies (MSAs). Interstitial lung disease (ILD) is a common manifestation of PM/DM, and it can even precede the onset of characteristic muscle or skin manifestations. Furthermore, t...
Guardado en:
Autores principales: | Abhinav K. Misra, Nathan L. Wong, Terrance T. Healey, Edward V. Lally, Barry S. Shea |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4b7d055effb443ce8e13b1e660035f3c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Miopatías inflamatorias idiopáticas: una mirada actualizada al diagnóstico y el manejo
por: Acosta,Ignacio, et al.
Publicado: (2019) -
Manifestaciones clínicas y anticuerpos asociados y específicos de miositis en 15 pacientes chilenos con dermatomiositis: serie clínica en un centro universitario
por: Maraví T.,Zósimo, et al.
Publicado: (2020) -
Dermatomyositis and/or polymyositis as a paraneoplastic manifestation of ovarian cancer: a systematic review
por: Victoria Psomiadou, et al.
Publicado: (2021) -
Myositis Specific Autoantibodies: A Clinical Perspective
por: Alenzi FM
Publicado: (2020) -
Skin Rash and Interstitial Pneumonia Can Be a Fatal Combination: A Rare Case of Anti-Melanoma Differentiation-Associated Gene 5 (MDA5)-Associated Interstitial Lung Disease
por: Giorgia Borio, et al.
Publicado: (2021)